We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against the ...

Novartis is buying Anthos Therapeutics from Blackstone’s drug development division, as it makes a bet on an experimental drug aimed at preventing strokes in patients with an irregular heart rhythm.

Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), a $15.77 billion market cap company with an "Excellent" financial health rating according to InvestingPro, executed a ...

"I would like to extend a warm welcome to Dan Kirby on behalf of the entire Iovance team,” stated Frederick Vogt, Ph.D., J.D., Interim President, Chief Executive Officer and board member of Iovance.

A Stoke-on-Trent MP has called on the government to support ceramics firms following the collapse of Royal Stafford. The ...

Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), recently executed a series of stock transactions, according to a recent SEC filing. On February 3, Benkowitz sold shares ...

Shares of Leap Therapeutics slid after disappointing initial ... a drug sold under the brand Avastin, and chemotherapy had an objective response rate of 35% and disease control rate of 86%.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Drug developers Aardvark Therapeutics, Aurion Biotech, Sonna Therapeutics, Metsera, and Odyssey Therapeutics are among the IPO hopefuls that have filed their paperwork in recent weeks. Maze ...

Clive Edwards, head of media and marketing at Peterborough United, said it had to consider how the crest was used - across the kit, on social media, and on "sub-brands" that did not exist in 2008.

Janux Therapeutics appointed Zachariah McIver to the role of chief medical officer. The San Diego-based biopharmaceutical company said Friday that McIver's expertise in T cell engagers ...